Allena Pharmaceuticals Stock Cash And Equivalents
| ALNAQDelisted Stock | USD 0 0.00 0.00% |
Allena Pharmaceuticals fundamentals help investors to digest information that contributes to Allena Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Allena Pink Sheet. The fundamental analysis module provides a way to measure Allena Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allena Pharmaceuticals pink sheet.
Allena |
Allena Pharmaceuticals Company Cash And Equivalents Analysis
Allena Pharmaceuticals' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Allena Pharmaceuticals Cash And Equivalents | 6.59 M |
Most of Allena Pharmaceuticals' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allena Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Allena Pharmaceuticals has 6.59 M in Cash And Equivalents. This is 99.2% lower than that of the Healthcare sector and 98.53% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 99.76% higher than that of the company.
Allena Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allena Pharmaceuticals' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Allena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Allena Pharmaceuticals by comparing valuation metrics of similar companies.Allena Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers.
Allena Fundamentals
| Return On Equity | -5.41 | |||
| Return On Asset | -1.07 | |||
| Current Valuation | (181.84 K) | |||
| Shares Outstanding | 122.08 M | |||
| Shares Owned By Insiders | 0.92 % | |||
| Shares Owned By Institutions | 0.26 % | |||
| Number Of Shares Shorted | 10.34 M | |||
| Price To Book | 0.30 X | |||
| EBITDA | (47.29 M) | |||
| Net Income | (48.66 M) | |||
| Cash And Equivalents | 6.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 5.28 M | |||
| Debt To Equity | 1.41 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (45.68 M) | |||
| Short Ratio | 0.62 X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.32 | |||
| Market Capitalization | 244.17 K | |||
| Total Asset | 34.76 M | |||
| Z Score | -3.3 | |||
| Net Asset | 34.76 M |
About Allena Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allena Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allena Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allena Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Allena Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allena Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allena Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Allena Pink Sheet
The ability to find closely correlated positions to Allena Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allena Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allena Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allena Pharmaceuticals to buy it.
The correlation of Allena Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allena Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allena Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allena Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |